{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:32:07Z","timestamp":1793770327848,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["24410741500"],"award-info":[{"award-number":["24410741500"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473342"],"award-info":[{"award-number":["82473342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124694","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:17:57Z","timestamp":1791818277000},"page":"124694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Regulating the iron-ROS cycle via electronic structure-engineered nanoregulators for Parkinson's disease therapy"],"prefix":"10.1016","volume":"338","author":[{"given":"Yanhui","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-5255","authenticated-orcid":false,"given":"Sharon","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-9882","authenticated-orcid":false,"given":"Heemin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-4226","authenticated-orcid":false,"given":"Rongqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124694_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib2","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1186\/s12889-025-23492-8","article-title":"The global, regional, and national burden of Parkinson's disease in 204 countries and territories, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"25","author":"Li","year":"2025","journal-title":"BMC Public Health"},{"issue":"10423","key":"10.1016\/j.biomaterials.2026.124694_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2026.124694_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41582-025-01163-x","article-title":"Characteristics and mechanisms of cognitive impairment in Parkinson disease","volume":"22","author":"Oikonomou","year":"2026","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124694_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","article-title":"Parkinson disease therapy: current strategies and future research priorities","volume":"20","author":"Stocchi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"10423","key":"10.1016\/j.biomaterials.2026.124694_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson's disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"issue":"10423","key":"10.1016\/j.biomaterials.2026.124694_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124694_bib8","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3390\/antiox13121462","article-title":"Role of oxidative stress in blood\u2013brain barrier disruption and neurodegenerative diseases","volume":"13","author":"Kim","year":"2024","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib9","article-title":"Oxidative stress: a new pathophysiological pathway in parkinson's disease and a potential target of the brain-sport crosstalk","volume":"2025","author":"Caproni","year":"2025","journal-title":"Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib11","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-024-49702-2","article-title":"Whole-exome sequencing identifies protein-coding variants associated with brain iron in 29,828 individuals","volume":"15","author":"Gong","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib12","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/s41467-024-47867-4","article-title":"Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease","volume":"15","author":"Fl\u00f8nes","year":"2024","journal-title":"Nat. Commun."},{"issue":"8006","key":"10.1016\/j.biomaterials.2026.124694_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","article-title":"Mitochondrial complex I activity in microglia sustains neuroinflammation","volume":"628","author":"Peruzzotti-Jametti","year":"2024","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124694_bib14","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41593-025-02010-4","article-title":"Hypoxia ameliorates neurodegeneration and movement disorder in a mouse model of Parkinson's disease","volume":"28","author":"Marutani","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib15","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41467-025-57142-9","article-title":"Dysregulation of mitochondrial \u03b1-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models","volume":"16","author":"Gao","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","article-title":"In defence of ferroptosis","volume":"10","author":"Alves","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124694_bib17","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1016\/j.cell.2025.09.010","article-title":"Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson's disease","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124694_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41583-025-00930-5","article-title":"Neuroferroptosis in health and diseases","volume":"26","author":"Lei","year":"2025","journal-title":"Nat. Rev. Neurosci."},{"issue":"6753","key":"10.1016\/j.biomaterials.2026.124694_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.adx0043","article-title":"Neuroinflammation across neurological diseases","volume":"388","author":"Shi","year":"2025","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124694_bib20","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124694_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","article-title":"Key genes and convergent pathogenic mechanisms in Parkinson disease","volume":"25","author":"Coukos","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124694_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409329","article-title":"Targeting the labile iron pool with engineered DFO nanosheets to inhibit ferroptosis for Parkinson's disease therapy","volume":"36","author":"Lei","year":"2024","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124694_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1474-4422(24)00097-8","article-title":"Negative findings from trials with NLY01 or deferiprone for Parkinson's disease","volume":"23","author":"M\u00fcller","year":"2024","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124694_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12072","article-title":"Development of novel carbon-based biomedical platforms for intervention in xenotoxicant-induced Parkinson's disease onset","volume":"2","author":"Kumar","year":"2024","journal-title":"BMEMat"},{"issue":"30","key":"10.1016\/j.biomaterials.2026.124694_bib26","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1002\/anie.201712469","article-title":"Carbon nanozymes: enzymatic properties, catalytic mechanism, and applications","volume":"57","author":"Sun","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2026.124694_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2022.214896","article-title":"Carbon-based nanozymes: design, catalytic mechanism, and bioapplication","volume":"475","author":"Sun","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124694_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139704","article-title":"Carbon-based nanozymes for cancer therapy and diagnosis: a review","volume":"297","author":"Cordani","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2026.124694_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.mser.2025.101024","article-title":"Carbon dots for reactive oxygen species modulation","volume":"166","author":"Xu","year":"2025","journal-title":"Mater. Sci. Eng. R Rep."},{"key":"10.1016\/j.biomaterials.2026.124694_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115644","article-title":"Carbon dots in drug delivery and therapeutic applications","volume":"224","author":"Singh","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124694_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107974","article-title":"Vagus nerve and brain\u2013gut communication in neurodegenerative diseases: mechanism and therapeutic perspectives","volume":"221","author":"Luo","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/13510002.2025.2455914","article-title":"Mesenchymal stem cells enhanced by salidroside to inhibit ferroptosis and improve premature ovarian insufficiency via Keap1\/Nrf2\/GPX4 signaling","volume":"30","author":"Chen","year":"2025","journal-title":"Redox Rep."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124694_bib33","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.xphs.2020.09.019","article-title":"Efficient LRP1-Mediated uptake and low cytotoxicity of peptide L57 in vitro shows its promise as CNS drug delivery vector","volume":"110","author":"Rodrigues","year":"2021","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.biomaterials.2026.124694_bib34","first-page":"135","article-title":"A novel LRP1-binding peptide L57 that crosses the blood brain barrier","volume":"12","author":"Sakamoto","year":"2017","journal-title":"Biochem. Biophys. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib35","article-title":"Salidroside protects dopaminergic neurons by enhancing PINK1\/Parkin-Mediated mitophagy","volume":"2019","author":"Li","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2017.13","article-title":"MPP+ induces necrostatin-1- and ferrostatin-1-sensitive necrotic death of neuronal SH-SY5Y cells","volume":"3","author":"Ito","year":"2017","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124694_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s42255-025-01224-x","article-title":"Pro-inflammatory macrophages produce mitochondria-derived superoxide by reverse electron transport at complex I that regulates IL-1\u03b2 release during NLRP3 inflammasome activation","volume":"7","author":"Casey","year":"2025","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124694_bib38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124694_bib39","first-page":"651","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Conrad","year":"2024","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124694_bib40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124694_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1471-4159.2007.04586.x","article-title":"Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum","volume":"102","author":"Bychkov","year":"2007","journal-title":"J. Neurochem."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226007180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226007180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:20:54Z","timestamp":1793769654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226007180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":41,"alternative-id":["S0142961226007180"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124694","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulating the iron-ROS cycle via electronic structure-engineered nanoregulators for Parkinson's disease therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124694"}}